Clinical effect of vascular targeting drugs combined with chemotherapy in advanced liver cancer

Abstract

To analyze the clinical effect of vascular targeted drug combined with chemotherapy in the treatment of advanced liver cancer, the clinical effect of middle and late liver cancer is the target of this investigation.50 patients treated in the oncology department of our hospital from 2021 to 2022. Groups were grouped according to different treatment modalities, and the number of cases per group was 25. The experimental group was treated with vascular targeted drugs + chemotherapy, and the control group was treated with chemotherapy. Compare the specific implementation of the two groups. Relevant indicators in the experimental group were better than those in the control group (P <0.05). After the intervention of vascular targeted drugs + chemotherapy, the safety of patients with advanced liver cancer is improved, the existence value of tumor markers is improved, the body immunity of patients is improved, and the treatment compliance of patients is improved, which is worth promoting.